Breakwater Capital Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.57M Sell
5,985
-2
-0% -$513 0.19% 119
2026
Q2
$1.51M Sell
5,987
-293
-5% -$63K 0.18% 127
2026
Q1
$1.37M Buy
6,280
+232
+4% +$51.5K 0.18% 127
2025
Q4
$1.38M Sell
6,048
-102
-2% -$23.2K 0.19% 113
2025
Q3
$1.42M Buy
6,150
+130
+2% +$26.5K 0.21% 106
2025
Q2
$1.12M Buy
6,020
+216
+4% +$40.1K 0.18% 119
2025
Q1
$1.22M Buy
5,804
+783
+16% +$152K 0.22% 104
2024
Q4
$892K Buy
5,021
+492
+11% +$90.5K 0.18% 122
2024
Q3
$894K Buy
4,529
+85
+2% +$15.9K 0.18% 117
2024
Q2
$762K Sell
4,444
-50
-1% -$8.28K 0.17% 127
2024
Q1
$818K Buy
4,494
+543
+14% +$93.6K 0.21% 107
2023
Q4
$653K Buy
3,951
+597
+18% +$87K 0.18% 107
2023
Q3
$478K Buy
3,354
+375
+13% +$55.1K 0.16% 119
2023
Q2
$401K Buy
2,979
+161
+6% +$23.6K 0.15% 137
2023
Q1
$449K Buy
2,818
+204
+8% +$31.2K 0.19% 116
2022
Q4
$422K Buy
+2,614
New +$401K 0.22% 105

Other funds holding ABBV

Breakwater Capital Group's ABBV Position: Q3 2026 in Review

Breakwater Capital Group reduced its AbbVie (ABBV) stake by 0.03% in Q3 2026, selling an estimated $513 and leaving 5,985 shares worth $1.57M. The position accounts for 0.19% of the portfolio, ranked #119.

Breakwater Capital Group first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Breakwater Capital Group held 5,985 shares of AbbVie worth $1.57M as of Q3 2026.
  • Breakwater Capital Group sold 2 AbbVie shares in Q3 2026, an estimated $513.
  • AbbVie made up 0.19% of Breakwater Capital Group's portfolio in Q3 2026, its #119 holding.
  • Breakwater Capital Group first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Breakwater Capital Group's 13F filing for Q3 2026, filed 9 Oct 2026.